US Approval of Engineered Mosquitoes Stalled for 15 Years
What happened
Oxitec inserts a lethal gene into male Aedes aegypti mosquitoes to shrink wild populations. Trials in the Cayman Islands cut the population by 80%, and trials in Brazil by 95%. The company has sought US approval since 2010, and reports say the technology has been stuck in regulation for 15 years. The US logged nearly 4,000 dengue cases in 2024, up 360% from the annual average of 830 over the past decade, with local transmission in Florida, California and Texas. An October 5, 2026 report ties US mosquito-borne disease spread to the long regulatory stall. No new approval decision was disclosed.
Written by AI from the coverage · updated 53 minutes ago
Coverage
Follow the reports to see the story from different sides.
- Hacker News front pageMosquitoes Are a Choice
美国2024年报告近4000例登革热病例，较过去十年年均830例增长360%，佛罗里达、加州和得州均出现本地传播。Oxitec将致死基因植入雄性埃及伊蚊，在开曼群岛和巴西试验中分别使野生种群减少80%和95%，但该技术自2010年申请美国审批以来已困于监管十五年。
Heat over time
Not enough continuous observations to draw a trend yet.